Exhibit 23.2
CONSENT OF INDEPENDENT AUDITOR
We hereby consent to the incorporation by reference, in this Registration Statement onForm S-3 of our report dated February 28, 2017, with respect to the consolidated financial statements of Otic Pharma Ltd. and its subsidiary (which comprise the balance sheets as of December 31, 2016 and 2015, and the related Statements of Operations, Changes in Shareholders Deficit and Cash Flows for the year and period then ended, and the related notes to the financial statements) appearing in the Definitive Proxy Statement on Schedule 14A, filed by Tokai Pharmaceuticals, Inc. on April 7, 2017, and to the reference of our Firm under the caption “Experts” in the Registration Statement.
| /s/ | Brightman, Almagor Zohar & Co. | |
| Brightman, Almagor Zohar & Co. | ||
| Certified Public Accountants | ||
| Member of Deloitte Touche Tohmatsu Limited | ||
| Tel Aviv, Israel | ||
| August 3, 2017 |
